查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
傳染病體外診斷市場規模及預測 2021-2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋範圍：應用、最終用戶及地理
市場調查報告書
商品編碼
1780324

傳染病體外診斷市場規模及預測 2021-2031、全球及地區佔有率、趨勢及成長機會分析報告涵蓋範圍：應用、最終用戶及地理

Infectious Disease In vitro Diagnostics Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 190 Pages | 訂單完成後即時交付

價格

傳染病體外診斷市場規模預計將從2024年的456.9億美元成長到2031年的767.1億美元；預計2025-2031年期間的複合年成長率為7.7%。傳染病的日益普及以及主要參與者的策略發展是推動傳染病體外診斷市場規模擴張的重要因素。然而，報銷機制的不足阻礙了傳染病體外診斷市場的成長。

分子診斷和自動化系統的開發與整合等技術進步，提高了傳染病檢測的準確性、速度和可及性。以下列舉一些例子：

2024 年 6 月，MP Biomedicals 推出了一系列針對幽門螺旋桿菌、傷寒沙門氏菌和霍亂弧菌的快速免疫層析檢測方法，旨在用於資源受限環境中的即時護理。

2024 年 6 月，羅氏公司的 cobas liat 多重 PCR 檢測板獲得 FDA 緊急使用授權 (EUA)，該檢測板可同時檢測 SARS-CoV-2、甲型/乙型流感和呼吸道合胞病毒，在不到 20 分鐘的時間內推進綜合性呼吸道感染管理。

2024年7月，Sherlock Biosciences啟動了其基於CRISPR的非處方（OTC）淋病和衣原體檢測的臨床試驗，並計劃於2025年上市。此外，該公司還推出了整合人工智慧和奈米技術機器學習的APEX-TB，旨在透過攜帶式設備提供精準的即時分子診斷。

2024 年 6 月，QIAGEN 向其數位 PCR (dPCR) 平台 QIAcuity 引入了 35 種新的濕實驗室測試數位 PCR 微生物 DNA 檢測檢測方法，顯著增強了其在微生物研究方面的能力。

這些進步是朝向分散化、以使用者為中心、快速診斷技術發展趨勢的一部分，這些技術將引領未來傳染病診療的發展。預計這將有助於未來幾年傳染病體外診斷市場的成長。

基於最終用戶的洞察

根據最終用戶，傳染病體外診斷市場可細分為醫院和診所、診斷實驗室、血庫和其他。 2024年，醫院和診所佔據了傳染病體外診斷市場的最大佔有率。由於拉沙熱、霍亂、結核病和瘧疾的頻繁爆發，醫院和診所對準確、及時診斷的需求正在穩步上升。不斷飆升的患者負擔和對優質護理的需求促使醫院採用更先進的診斷工具，包括分子診斷。政府資金投入、捐助者支持以及二級和三級醫院基礎設施的改善進一步推動了體外診斷產品的普及。將體外診斷納入醫院診療方案可以改善患者預後，減少不必要的抗生素使用，並確保城鄉衛生中心更好地管理傳染病，從而推動傳染病體外診斷市場的成長。

世界衛生組織和墨西哥衛生部國家呼吸道疾病研究所是撰寫傳染病體外診斷市場報告時參考的主要和次要來源。

目錄

第1章：簡介

第2章：執行摘要

  • 分析師市場展望

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：
  • 假設和局限性

第4章：傳染病體外診斷市場格局

  • 概述
  • PEST分析

第5章：傳染病體外診斷市場－關鍵市場動態

  • 傳染病體外診斷市場－關鍵市場動態
  • 市場促進因素
    • 傳染病日益流行
    • 關鍵參與者的策略發展
  • 市場限制
    • 報銷不足的情況
  • 市場機會
    • 政府提高民眾對傳染病意識的舉措
  • 未來趨勢
    • 技術進步
  • 促進因素和限制因素的影響：

第6章：傳染病體外診斷市場-全球市場分析

  • 傳染病體外診斷市場收入（2021-2031）
  • 傳染病體外診斷市場預測分析

第7章：傳染病體外診斷市場分析-按應用

  • HIV或愛滋病
  • 結核
  • 乙型肝炎及丙型肝炎
  • 瘧疾
  • 其他

第 8 章：傳染病體外診斷市場分析 - 依最終用戶

  • 醫院和診所
  • 診斷實驗室
  • 血庫
  • 其他

第9章：傳染病體外診斷市場-地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第10章：競爭格局

  • 關鍵參與者的熱圖分析
  • 公司定位與集中度

第 11 章：產業格局

  • 概述
  • 全球傳染病體外診斷市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第12章：公司簡介

  • ABBOTT LABORATORIES
  • F. HOFFMANN-LA ROCHE LTD
  • BECTON DICKINSON AND CO
  • SYSMEX CORP
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES INC
  • QIAGEN NV
  • QUIDELORTHO CORP
  • BRUKER CORP
  • DANAHER CORP

第 13 章：附錄

Product Code: TIPRE00040978

The infectious disease in vitro diagnostics market size is expected to grow from US$ 45.69 billion in 2024 to US$ 76.71 billion by 2031; it is projected to register a CAGR of 7.7% during 2025-2031. The increasing prevalence of infectious diseases and strategic developments by key players are noteworthy factors contributing to the expansion of the infectious disease in vitro diagnostics market size. However, the inadequate reimbursement scenario hinders the infectious disease in vitro diagnostics market growth.

Technological advancements involving the development and integration of molecular diagnostics and automation systems enhance the accuracy, speed, and accessibility of infectious disease detection. Below are a few instances:

In June 2024, MP Biomedicals introduced a new line of rapid immunochromatographic assays for Helicobacter pylori, Salmonella typhi, and Vibrio cholerae, intended for point-of-care in resource-constrained environments.

In June 2024, Roche gained FDA Emergency Use Authorization (EUA) for its cobas liat multiplex PCR panel updated to detect SARS-CoV-2, influenza A/B, and RSV simultaneously, advancing syndromic respiratory infection management in less than 20 minutes.

In July 2024, Sherlock Biosciences initiated clinical trials for its CRISPR-based over-the-counter (OTC) test for gonorrhea and chlamydia in May 2024, with an eye toward a 2025 launch. APEX-TB, integrating machine learning from AI and nanotechnology, was also launched to provide accurate, real-time molecular diagnostics using portable devices.

In June 2024, QIAGEN introduced 35 new wet-lab tested digital PCR Microbial DNA Detection Assays to its digital PCR (dPCR) platform QIAcuity, noticeably strengthening its capabilities in microbial research.

These advancements are part of a larger movement toward decentralized, user-centric, and fast diagnostic technologies guiding the future of infectious disease care. This is expected to contribute to the growth of the infectious disease in vitro diagnostics market in the coming years.

End User -Based Insights

Based on end user, the infectious disease in vitro diagnostics market is segmented into hospitals and clinics, diagnostics laboratories, blood bank, and others. The hospitals and clinics segment held the largest infectious disease in vitro diagnostics market share in 2024. The need for accurate, timely diagnosis in hospitals and clinics is rising steadily due to frequent outbreaks of Lassa fever, cholera, tuberculosis, and malaria. The soaring patient load and demand for quality care have pushed hospitals to adopt more sophisticated diagnostic tools, including molecular diagnostics. Increased government funding, donor support, and infrastructure improvements in secondary and tertiary hospitals further boost the adoption of IVD products. Integrating IVD in hospital protocols improves patient outcomes, reduces unnecessary antibiotic use, and ensures better management of infectious diseases in urban and rural health centers, thereby fueling the infectious disease in vitro diagnostics market growth.

The World Health Organization and Mexico's Ministry of Health's National Institute of Respiratory Diseases are among the primary and secondary sources referred to while preparing the infectious disease in vitro diagnostics market report.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Analyst Market Outlook

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:
  • 3.3 Assumptions and Limitations

4. Infectious Disease In vitro Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Infectious Disease In vitro Diagnostics Market - Key Market Dynamics

  • 5.1 Infectious Disease In vitro Diagnostics Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Infectious Diseases
    • 5.2.2 Strategic Developments by Key Players
  • 5.3 Market Restraints
    • 5.3.1 Inadequate Reimbursement Scenario
  • 5.4 Market Opportunities
    • 5.4.1 Government Initiatives to Increase Awareness Regarding Infectious Diseases
  • 5.5 Future Trends
    • 5.5.1 Technological Advancements
  • 5.6 Impact of Drivers and Restraints:

6. Infectious Disease In vitro Diagnostics Market - Global Market Analysis

  • 6.1 Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
  • 6.2 Infectious Disease In vitro Diagnostics Market Forecast Analysis

7. Infectious Disease In vitro Diagnostics Market Analysis - by Applications

  • 7.1 HIV or AIDS
    • 7.1.1 Overview
    • 7.1.2 HIV or AIDS: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Tuberculosis
    • 7.2.1 Overview
    • 7.2.2 Tuberculosis: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Hepatitis B and C
    • 7.3.1 Overview
    • 7.3.2 Hepatitis B and C: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Malaria
    • 7.4.1 Overview
    • 7.4.2 Malaria: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

8. Infectious Disease In vitro Diagnostics Market Analysis - by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Overview
    • 8.1.2 Hospitals and Clinics: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Overview
    • 8.2.2 Diagnostic Laboratories: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Blood Bank
    • 8.3.1 Overview
    • 8.3.2 Blood Bank: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Others
    • 8.4.1 Overview
    • 8.4.2 Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)

9. Infectious Disease In vitro Diagnostics Market - Geographical Analysis

  • 9.1 Overview
  • 9.2 North America
    • 9.2.1 North America Infectious Disease In vitro Diagnostics Market Overview
    • 9.2.2 North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.2.2.1 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.2.2.2 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.2.3 North America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 United States: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.2.3.1.1 United States: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.2.3.1.2 United States: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.2.3.2 Canada: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.2.3.2.1 Canada: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.2.3.2.2 Canada: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.2.3.3 Mexico: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.2.3.3.1 Mexico: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.2.3.3.2 Mexico: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  • 9.3 Europe
    • 9.3.1 Europe Infectious Disease In vitro Diagnostics Market Overview
    • 9.3.2 Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.3.2.1 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.3.2.2 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.3.3 Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.1.1 United Kingdom: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.1.2 United Kingdom: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.2 Germany: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.2.1 Germany: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.2.2 Germany: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.3 France: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.3.1 France: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.3.2 France: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.4 Italy: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.4.1 Italy: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.4.2 Italy: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.5 Spain: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.5.1 Spain: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.5.2 Spain: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.3.3.6 Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.3.3.6.1 Rest of Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.3.3.6.2 Rest of Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  • 9.4 Asia Pacific
    • 9.4.1 Asia Pacific Infectious Disease In vitro Diagnostics Market Overview
    • 9.4.2 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.4.2.1 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.4.2.2 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.4.3 Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 China: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.1.1 China: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.1.2 China: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.2 Japan: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.2.1 Japan: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.2.2 Japan: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.3 India: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.3.1 India: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.3.2 India: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.4 Australia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.4.1 Australia: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.4.2 Australia: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.5 South Korea: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.5.1 South Korea: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.5.2 South Korea: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.4.3.6 Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.4.3.6.1 Rest of APAC: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.4.3.6.2 Rest of APAC: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East and Africa Infectious Disease In vitro Diagnostics Market Overview
    • 9.5.2 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.5.2.1 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.5.2.2 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.5.3 Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 South Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.5.3.1.1 South Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.5.3.1.2 South Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.5.3.2 Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.5.3.2.1 Saudi Arabia: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.5.3.2.2 Saudi Arabia: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.5.3.3 United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.5.3.3.1 United Arab Emirates: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.5.3.3.2 United Arab Emirates: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.5.3.4 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.5.3.4.1 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.5.3.4.2 Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
  • 9.6 South and Central America
    • 9.6.1 South and Central America Infectious Disease In vitro Diagnostics Market Overview
    • 9.6.2 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
      • 9.6.2.1 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Applications
      • 9.6.2.2 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by End User
    • 9.6.3 South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast Analysis - by Country
      • 9.6.3.1 Brazil: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.6.3.1.1 Brazil: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.6.3.1.2 Brazil: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.6.3.2 Argentina: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.6.3.2.1 Argentina: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.6.3.2.2 Argentina: Infectious Disease In vitro Diagnostics Market Breakdown, by End User
      • 9.6.3.3 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.6.3.3.1 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by Applications
        • 9.6.3.3.2 Rest of South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by End User

10. Competitive Landscape

  • 10.1 Heat Map Analysis by Key Players
  • 10.2 Company Positioning & Concentration

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
  • 11.3 Organic Growth Strategies
    • 112.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 112.4.1 Overview

12. Company Profiles

  • 12.1. ABBOTT LABORATORIES
    • 12.1.1. Key Facts
    • 12.1.2. Business Description
    • 12.1.3. Products and Services
    • 12.1.4. Financial Overview
    • 12.1.5. SWOT Analysis
    • 12.1.6. Key Developments
  • 12.2. F. HOFFMANN-LA ROCHE LTD
    • 12.2.1. Key Facts
    • 12.2.2. Business Description
    • 12.2.3. Products and Services
    • 12.2.4. Financial Overview
    • 12.2.5. SWOT Analysis
    • 12.2.6. Key Developments
  • 12.3. BECTON DICKINSON AND CO
    • 12.3.1. Key Facts
    • 12.3.2. Business Description
    • 12.3.3. Products and Services
    • 12.3.4. Financial Overview
    • 12.3.5. SWOT Analysis
    • 12.3.6. Key Developments
  • 12.4. SYSMEX CORP
    • 12.4.1. Key Facts
    • 12.4.2. Business Description
    • 12.4.3. Products and Services
    • 12.4.4. Financial Overview
    • 12.4.5. SWOT Analysis
  • 12.5. BIOMERIEUX SA
    • 12.5.1. Key Facts
    • 12.5.2. Business Description
    • 12.5.3. Products and Services
    • 12.5.4. Financial Overview
    • 12.5.5. SWOT Analysis
    • 12.5.6. Key Developments
  • 12.6. BIO-RAD LABORATORIES INC
    • 12.6.1. Key Facts
    • 12.6.2. Business Description
    • 12.6.3. Products and Services
    • 12.6.4. Financial Overview
    • 12.6.5. SWOT Analysis
    • 12.6.6. Key Developments
  • 12.6. QIAGEN NV
    • 12.6.1. Key Facts
    • 12.6.2. Business Description
    • 12.6.3. Products and Services
    • 12.6.4. Financial Overview
    • 12.6.5. SWOT Analysis
    • 12.6.6. Key Developments
  • 12.8. QUIDELORTHO CORP
    • 12.8.1. Key Facts
    • 12.8.2. Business Description
    • 12.8.3. Products and Services
    • 12.8.4. Financial Overview
    • 12.8.5. SWOT Analysis
    • 12.8.6. Key Developments
  • 12.9. BRUKER CORP
    • 12.9.1. Key Facts
    • 12.9.2. Business Description
    • 12.9.3. Products and Services
    • 12.9.4. Financial Overview
    • 12.9.5. SWOT Analysis
    • 12.9.6. Key Developments
  • 12.10. DANAHER CORP
    • 12.10.1. Key Facts
    • 12.10.2. Business Description
    • 12.10.3. Products and Services
    • 12.10.4. Financial Overview
    • 12.10.5. SWOT Analysis
    • 12.10.6. Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Infectious Disease In vitro Diagnostics Market Segmentation
  • Table 2. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million)
  • Table 3. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million)
  • Table 4. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 5. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 6. Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 7. Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 8. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 9. North America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 10. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 11. North America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 12. United States: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 13. United States: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 14. United States: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 15. United States: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 16. Canada: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 17. Canada: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 18. Canada: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 19. Canada: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 20. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 21. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 22. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 23. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 24. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 25. Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 26. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 27. Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 28. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 29. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 30. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 31. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 32. Germany: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 33. Germany: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 34. Germany: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 35. Germany: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 36. France: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 37. France: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 38. France: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 39. France: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 40. Italy: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 41. Italy: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 42. Italy: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 43. Italy: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 44. Spain: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 45. Spain: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 46. Spain: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 47. Spain: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 48. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 49. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 50. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 51. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 52. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 53. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 54. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 55. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 56. China: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 57. China: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 58. China: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 59. China: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 60. Japan: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 61. Japan: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 62. Japan: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 63. Japan: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 64. India: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 65. India: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 66. India: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 67. India: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 68. Australia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 69. Australia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 70. Australia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 71. Australia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 72. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 73. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 74. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 75. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 76. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 77. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 78. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 79. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 80. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 81. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 82. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 83. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 84. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 85. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 86. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 87. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 88. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 89. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 90. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 91. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 92. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 93. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 94. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 95. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 96. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 97. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 98. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 99. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 100. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 101. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 102. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 103. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 104. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 105. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 106. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 107. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 108. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 109. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 110. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 111. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 112. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by Applications
  • Table 113. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by Applications
  • Table 114. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 115. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 116. Heat Map Analysis by Key Players
  • Table 117. Recent Organic Growth Strategies in the global Infectious Disease In-Vitro Diagnostics Market
  • Table 118. Recent Inorganic Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market
  • Table 119. Glossary of Terms, Infectious Disease In vitro Diagnostics Market

List Of Figures

  • Figure 1. Infectious Disease In vitro Diagnostics Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Infectious Disease In vitro Diagnostics Market Revenue (US$ Million), 2021-2031
  • Figure 5. Infectious Disease In vitro Diagnostics Market Share (%) - by Applications (2024 and 2031)
  • Figure 6. HIV or AIDS: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Tuberculosis: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Hepatitis B and C: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Malaria: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Infectious Disease In vitro Diagnostics Market Share (%) - by End User (2024 and 2031)
  • Figure 12. Hospitals and Clinics: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Diagnostic Laboratories: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Blood Bank: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Infectious Disease In vitro Diagnostics Market Breakdown by Region, 2024 and 2031 (%)
  • Figure 17. North America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 18. North America: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 19. United States: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Canada: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Mexico: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 22. Europe: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 23. Europe: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 24. United Kingdom: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 25. Germany: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 26. France: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 27. Italy: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 28. Spain: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 29. Rest of Europe: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 30. Asia Pacific: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 31. Asia Pacific: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 32. China: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 33. Japan: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 34. India: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 35. Australia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 36. South Korea: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 37. Rest of APAC: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 38. Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 39. Middle East and Africa: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 40. South Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 41. Saudi Arabia: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 42. United Arab Emirates: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 43. Rest of Middle East and Africa: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 44. South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue, 2021-2031 (US$ Million)
  • Figure 45. South and Central America: Infectious Disease In vitro Diagnostics Market Breakdown, by Key Countries, 2024 and 2031 (%)
  • Figure 46. Brazil: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 47. Argentina: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 48. Rest of South and Central America: Infectious Disease In vitro Diagnostics Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 49. Company Positioning & Concentration
  • Figure 50. Growth Strategies in the Global Infectious Disease In-Vitro Diagnostics Market - Global Infectious Disease In vitro Diagnostics Market